Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.

Entyvio_Logo_PMS_254.jpg

Account Manager Contact

Sheri McCampbell, RD

Senior Key Account Manager

IBD and rare disease

310-508-1332

Sheri.mccampbell@takeda.com

www.takeda.com

Better Health, Brighter Future

Follow us on LinkedIn

ABOUT US

The Southern California Society of Gastroenterology (SCSG) is a non-profit professional society dedicated to enhancing the practice of gastroenterology by enriching gastroenterologists in the region through continuing medical education. 

The SCSG aims to provide an environment of professional growth and social exchange for its members

Privacy:

We take our privacy seriously, please click here to view our Privacy Notice.

CONTACT US

1400 N. Harbor Blvd.
Suite 625

Fullerton, CA 92835

 

Registration/Membership Inquiries contact:

336.698.6368
 

Sponsorship Inquiries contact:

714.869.2989

Fax: 866.735.4373

scsg@pacemedcom.com

SUBSCRIBE TO EMAILS
  • Grey Facebook Icon

© 2021 Southern California Society of Gastroenterology